{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:21:40Z","timestamp":1794543700132,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sao Paulo Research Foundation","award":["#2018\/26528-5"],"award-info":[{"award-number":["#2018\/26528-5"]}]},{"name":"Sao Paulo Research Foundation","award":["#2017\/02020-0"],"award-info":[{"award-number":["#2017\/02020-0"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Focal segmental glomerulosclerosis (FSGS) is the leading cause of nephrotic syndrome, which is characterized by podocyte injury. Given that the pathophysiology of nondiabetic glomerulosclerosis is poorly understood and targeted therapies to prevent glomerular disease are lacking, we decided to investigate the tight junction protein claudin-1 and the histone deacetylase sirtuin-1 (SIRT1), which are known to be involved in podocyte injury. For this purpose, we first examined SIRT1, claudin-1 and podocin expression in kidney biopsies from patients diagnosed with nondiabetic FSGS and found that upregulation of glomerular claudin-1 accompanies a significant reduction in glomerular SIRT1 and podocin levels. From this, we investigated whether a small molecule activator of SIRT1, SRT1720, could delay the onset of FSGS in an animal model of adriamycin (ADR)-induced nephropathy; 14\u00a0days of treatment with SRT1720 attenuated glomerulosclerosis progression and albuminuria, prevented transcription factor Wilms tumor 1 (WT1) downregulation and increased glomerular claudin-1 in the ADR\u2009+\u2009SRT1720 group. Thus, we evaluated the effect of ADR and\/or SRT1720 in cultured mouse podocytes. The results showed that ADR [1\u00a0\u00b5M] triggered an increase in claudin-1 expression after 30\u00a0min, and this effect was attenuated by pretreatment of podocytes with SRT1720 [5\u00a0\u00b5M]. ADR [1\u00a0\u00b5M] also led to changes in the localization of SIRT1 and claudin-1 in these cells, which could be associated with podocyte injury. Although the use of specific agonists such as SRT1720 presents some benefits in glomerular function, their underlying mechanisms still need to be further explored for therapeutic use. Taken together, our data indicate that SIRT1 and claudin-1 are relevant for the pathophysiology of nondiabetic FSGS.<\/jats:p>","DOI":"10.1038\/s41598-023-49861-0","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T21:32:53Z","timestamp":1703021573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of glomerular sirtuin-1 and claudin-1 in the pathophysiology of nondiabetic focal segmental glomerulosclerosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Guilherme","family":"Lopes-Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Martins","family":"Costa-Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruan","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Flavia","family":"Tostes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa Martins","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Louren\u00e7o","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Maria Avancini Costa","family":"Malheiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Zatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Olsen Saraiva","family":"C\u00e2mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Oliveira-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"1","key":"49861_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244677","volume":"16","author":"T Ozeki","year":"2021","unstructured":"Ozeki, T. et al. Nephrotic syndrome with focal segmental glomerular lesions unclassified by Columbia classification; Pathology and clinical implication. PLoS\u00a0One 16(1), e0244677 (2021).","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"49861_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.kint.2022.02.037","volume":"102","author":"F Li","year":"2022","unstructured":"Li, F. et al. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis. Kidney Int. 102(1), 121\u2013135 (2022).","journal-title":"Kidney Int."},{"issue":"3","key":"49861_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg, A. Z. & Kopp, J. B. Focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 12(3), 502\u2013517 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"49861_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli, M. et al. Minimal change disease. Clin. J. Am. Soc. Nephrol. 12(2), 332\u2013345 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"49861_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000517108","volume":"7","author":"K Sun","year":"2021","unstructured":"Sun, K., Xie, Q. & Hao, C. M. Mechanisms of scarring in focal segmental glomerulosclerosis. Kidney Dis. (Basel) 7(5), 350\u2013358 (2021).","journal-title":"Kidney Dis. (Basel)"},{"issue":"9","key":"49861_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1369\/0022155419850170","volume":"67","author":"J Zhong","year":"2019","unstructured":"Zhong, J. et al. Mechanisms of scarring in focal segmental glomerulosclerosis. J. Histochem. Cytochem. 67(9), 623\u2013632 (2019).","journal-title":"J. Histochem. Cytochem."},{"issue":"2","key":"49861_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo, A. B. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat. Rev. Nephrol. 11(2), 76\u201387 (2015).","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"49861_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1681\/ASN.2017090958","volume":"29","author":"AS De Vriese","year":"2018","unstructured":"De Vriese, A. S. et al. Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. J. Am. Soc. Nephrol. 29(3), 759\u2013774 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"49861_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"AK Cheung","year":"2021","unstructured":"Cheung, A. K. et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 99(3), S1\u2013S87 (2021).","journal-title":"Kidney Int."},{"key":"49861_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3765608","volume":"2016","author":"E K\u00f6nigshausen","year":"2016","unstructured":"K\u00f6nigshausen, E. & Sellin, L. Circulating permeability factors in primary focal segmental glomerulosclerosis: A review of proposed candidates. Biomed Res. Int. 2016, 3765608 (2016).","journal-title":"Biomed Res. Int."},{"issue":"12","key":"49861_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123292","volume":"11","author":"A Musia\u0142a","year":"2022","unstructured":"Musia\u0142a, A. et al. Biomarkers in primary focal segmental glomerulosclerosis in optimal diagnostic-therapeutic strategy. J. Clin. Med. 11(12), 3292 (2022).","journal-title":"J. Clin. Med."},{"issue":"10","key":"49861_CR12","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1681\/ASN.2017020174","volume":"28","author":"R Nishizono","year":"2017","unstructured":"Nishizono, R. et al. FSGS as an adaptive response to growth-induced podocyte stress. J. Am. Soc. Nephrol. 28(10), 2931\u20132945 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"49861_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41581-021-00427-1","volume":"17","author":"AS De Vriese","year":"2021","unstructured":"De Vriese, A. S. et al. Therapeutic trials in adult FSGS: Lessons learned and the road forward. Nat. Rev. Nephrol. 17(9), 619\u2013630 (2021).","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"49861_CR14","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/cells9071700","volume":"9","author":"J Blaine","year":"2020","unstructured":"Blaine, J. & Dylewski, J. Regulation of the actin cytoskeleton in podocytes. Cells 9(7), 1700 (2020).","journal-title":"Cells"},{"issue":"S4","key":"49861_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.33594\/000000356","volume":"55","author":"G Li","year":"2021","unstructured":"Li, G. et al. Podocyte sphingolipid signaling in nephrotic syndrome. Cell. Physiol. Biochem. 55(S4), 13\u201334 (2021).","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"49861_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36933-9","volume":"8","author":"GL Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves, G. L. et al. Intracellular albumin overload elicits endoplasmic reticulum stress and PKC-delta\/p38 MAPK pathway activation to induce podocyte apoptosis. Sci. Rep. 8(1), 18012 (2018).","journal-title":"Sci. Rep."},{"issue":"4","key":"49861_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/01913123.2011.584657","volume":"35","author":"S Darouich","year":"2011","unstructured":"Darouich, S. et al. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis. Ultrastruct. Pathol. 35(4), 176\u2013182 (2011).","journal-title":"Ultrastruct. Pathol."},{"issue":"3","key":"49861_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1681\/ASN.2013101067","volume":"26","author":"L Zhou","year":"2015","unstructured":"Zhou, L. et al. Mutual antagonism of Wilms\u2019 tumor 1 and \u03b2-catenin dictates podocyte health and disease. J. Am. Soc. Nephrol. 26(3), 677\u2013691 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"49861_CR19","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s00467-011-1824-y","volume":"26","author":"J Li","year":"2011","unstructured":"Li, J., Ananthapanyasut, W. & Yu, A. S. Claudins in renal physiology and disease. Pediatr. Nephrol. 26(12), 2133\u20132142 (2011).","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"49861_CR20","doi-asserted-by":"publisher","first-page":"F20","DOI":"10.1152\/ajprenal.00052.2005","volume":"290","author":"DB Lee","year":"2006","unstructured":"Lee, D. B., Huang, E. & Ward, H. J. Tight junction biology and kidney dysfunction. Am. J. Physiol. Renal Physiol. 290(1), F20\u2013F34 (2006).","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"7","key":"49861_CR21","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/ndt\/gfq006","volume":"25","author":"A Kirk","year":"2010","unstructured":"Kirk, A. et al. Differential expression of claudin tight junction proteins in the human cortical nephron. Nephrol. Dial. Transplant. 25(7), 2107\u20132119 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"49861_CR22","doi-asserted-by":"crossref","unstructured":"Elhefnawy, N. G. et al. Potential role of claudin-1 immunohistochemical expression and ultrastructural changes in detecting early focal segmental glomerulosclerosis. J. Nephropathol. 8(3), 1\u20138 (2019).","DOI":"10.15171\/jnp.2019.24"},{"issue":"12","key":"49861_CR23","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1016\/j.ajpath.2014.08.007","volume":"184","author":"B Smeets","year":"2014","unstructured":"Smeets, B. et al. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. Am. J. Pathol. 184(12), 3239\u20133248 (2014).","journal-title":"Am. J. Pathol."},{"issue":"11","key":"49861_CR24","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/nm.3363","volume":"19","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa, K. et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat. Med. 19(11), 1496\u20131504 (2013).","journal-title":"Nat. Med."},{"issue":"11","key":"49861_CR25","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nm.3386","volume":"19","author":"D Nihalani","year":"2013","unstructured":"Nihalani, D. & Susztak, K. Sirt1-Claudin-1 crosstalk regulates renal function. Nat. Med. 19(11), 1371\u20131372 (2013).","journal-title":"Nat. Med."},{"issue":"8","key":"49861_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10157-019-01719-4","volume":"23","author":"K Hasegawa","year":"2019","unstructured":"Hasegawa, K. Novel tubular-glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017. Clin. Exp. Nephrol. 23(8), 987\u2013994 (2019).","journal-title":"Clin. Exp. Nephrol."},{"issue":"7","key":"49861_CR27","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1681\/ASN.2017111218","volume":"29","author":"M Morigi","year":"2018","unstructured":"Morigi, M., Perico, L. & Benigni, A. Sirtuins in renal health and disease. J. Am. Soc. Nephrol. 29(7), 1799\u20131809 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"49861_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2119\/molmed.2014.00211","volume":"21","author":"L Kong","year":"2015","unstructured":"Kong, L. et al. Sirtuin 1: A target for kidney diseases. Mol. Med. 21, 87\u201397 (2015).","journal-title":"Mol. Med."},{"key":"49861_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep32787","volume":"6","author":"SY Yang","year":"2016","unstructured":"Yang, S. Y. et al. A low-salt diet increases the expression of renal sirtuin 1 through activation of the ghrelin receptor in rats. Sci. Rep. 6, 32787 (2016).","journal-title":"Sci. Rep."},{"key":"49861_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fendo.2018.00624","volume":"9","author":"Y Zhong","year":"2018","unstructured":"Zhong, Y., Lee, K. & He, J. C. SIRT1 is a potential drug target for treatment of diabetic kidney disease. Front. Endocrinol. (Lausanne) 9, 624 (2018).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"49861_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbrc.2008.04.176","volume":"372","author":"K Hasegawa","year":"2008","unstructured":"Hasegawa, K. et al. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem. Biophys. Res. Commun. 372(1), 51\u201356 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"49861_CR32","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung, F. et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23(12), 2369\u20132380 (2004).","journal-title":"EMBO J."},{"issue":"5","key":"49861_CR33","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/art.39061","volume":"67","author":"J Wei","year":"2015","unstructured":"Wei, J. et al. The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor \u03b2 signaling. Arthritis Rheumatol. 67(5), 1323\u20131334 (2015).","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"49861_CR34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.kint.2017.12.008","volume":"93","author":"Q Hong","year":"2018","unstructured":"Hong, Q. et al. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. Kidney Int. 93(6), 1330\u20131343 (2018).","journal-title":"Kidney Int."},{"key":"49861_CR35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.12659\/MSM.911714","volume":"25","author":"T Zhang","year":"2019","unstructured":"Zhang, T. et al. Resveratrol reduces oxidative stress and apoptosis in podocytes via Sir2-related enzymes, sirtuins1 (SIRT1)\/peroxisome proliferator-activated receptor \u03b3 co-activator 1\u03b1 (PGC-1\u03b1) axis. Med. Sci. Monit. 25, 1220\u20131231 (2019).","journal-title":"Med. Sci. Monit."},{"key":"49861_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/843786","volume":"2014","author":"YJ Dong","year":"2014","unstructured":"Dong, Y. J. et al. Renal protective effect of sirtuin 1. J. Diabetes Res. 2014, 843786 (2014).","journal-title":"J. Diabetes Res."},{"issue":"5","key":"49861_CR37","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.celrep.2014.01.031","volume":"6","author":"SJ Mitchell","year":"2014","unstructured":"Mitchell, S. J. et al. The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 6(5), 836\u2013843 (2014).","journal-title":"Cell Rep."},{"issue":"5","key":"49861_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cmet.2008.08.017","volume":"8","author":"JN Feige","year":"2008","unstructured":"Feige, J. N. et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 8(5), 347\u2013358 (2008).","journal-title":"Cell Metab."},{"key":"49861_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.924751","volume":"10","author":"C Bryant","year":"2022","unstructured":"Bryant, C. et al. Adriamycin-induced nephropathy is robust in N and modest in J substrain of C57BL\/6. Front. Cell Dev. Biol. 10, 924751 (2022).","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"49861_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","volume":"16","author":"VW Lee","year":"2011","unstructured":"Lee, V. W. & Harris, D. C. Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology (Carlton) 16(1), 30\u201338 (2011).","journal-title":"Nephrology (Carlton)"},{"issue":"9","key":"49861_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrneph.2015.88","volume":"11","author":"L Zhou","year":"2015","unstructured":"Zhou, L. & Liu, Y. Wnt\/\u03b2-catenin signalling and podocyte dysfunction in proteinuric kidney disease. Nat. Rev. Nephrol. 11(9), 535\u2013545 (2015).","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"49861_CR42","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","volume":"58","author":"Y Wang","year":"2000","unstructured":"Wang, Y. et al. Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int. 58(4), 1797\u20131804 (2000).","journal-title":"Kidney Int."},{"issue":"22","key":"49861_CR43","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.4103\/0366-6999.245266","volume":"131","author":"L Lyu","year":"2018","unstructured":"Lyu, L. et al. Serum metabolic profiling in a mouse model of adriamycin-induced focal segmental glomerulosclerosis. Chin. Med. J. (Engl) 131(22), 2743\u20132746 (2018).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"6","key":"49861_CR44","doi-asserted-by":"publisher","first-page":"F1566","DOI":"10.1152\/ajprenal.00214.2009","volume":"297","author":"T Ohse","year":"2009","unstructured":"Ohse, T. et al. A new function for parietal epithelial cells: A second glomerular barrier. Am. J. Physiol. Renal Physiol. 297(6), F1566\u2013F1574 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"49861_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1523\/JNEUROSCI.1432-18.2018","volume":"39","author":"N Sladojevic","year":"2019","unstructured":"Sladojevic, N. et al. Claudin-1-dependent destabilization of the blood\u2013brain barrier in chronic stroke. J. Neurosci. 39(4), 743\u2013757 (2019).","journal-title":"J. Neurosci."},{"issue":"2","key":"49861_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7150\/ijms.6.93","volume":"6","author":"AD French","year":"2009","unstructured":"French, A. D. et al. PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int. J. Med. Sci. 6(2), 93\u2013101 (2009).","journal-title":"Int. J. Med. Sci."},{"issue":"7","key":"49861_CR47","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.4049\/jimmunol.178.7.4641","volume":"178","author":"RM Al-Sadi","year":"2007","unstructured":"Al-Sadi, R. M. & Ma, T. Y. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178(7), 4641\u20134649 (2007).","journal-title":"J. Immunol."},{"issue":"1","key":"49861_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30526-2","volume":"8","author":"D Maria-Ferreira","year":"2018","unstructured":"Maria-Ferreira, D. et al. Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells. Sci. Rep. 8(1), 12261 (2018).","journal-title":"Sci. Rep."},{"issue":"14","key":"49861_CR49","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/pros.24046","volume":"80","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. Tight junction protein claudin-1 is downregulated by TGF-\u03b21 via MEK signaling in benign prostatic epithelial cells. Prostate 80(14), 1203\u20131215 (2020).","journal-title":"Prostate"},{"issue":"3","key":"49861_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265081","volume":"17","author":"M Iida","year":"2022","unstructured":"Iida, M. et al. TNF-\u03b1 induces Claudin-1 expression in renal tubules in Alport mice. PLoS\u00a0One 17(3), e0265081 (2022).","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"49861_CR51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1681\/ASN.2015121324","volume":"28","author":"Y Gong","year":"2017","unstructured":"Gong, Y. et al. Inducible expression of claudin-1 in glomerular podocytes generates aberrant tight junctions and proteinuria through slit diaphragm destabilization. J. Am. Soc. Nephrol. 28(1), 106\u2013117 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"49861_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000447067","volume":"133","author":"JW Chang","year":"2016","unstructured":"Chang, J. W. et al. Up-regulation of SIRT1 reduces endoplasmic reticulum stress and renal fibrosis. Nephron 133(2), 116\u2013128 (2016).","journal-title":"Nephron"},{"issue":"2","key":"49861_CR53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/jpet.115.224386","volume":"354","author":"M Ponnusamy","year":"2015","unstructured":"Ponnusamy, M. et al. Activation of sirtuin-1 promotes renal fibroblast activation and aggravates renal fibrogenesis. J. Pharmacol. Exp. Ther. 354(2), 142\u2013151 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"49861_CR54","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/2211-5463.12895","volume":"10","author":"JY Sung","year":"2020","unstructured":"Sung, J. Y. et al. SRT1720-induced activation of SIRT1 alleviates vascular smooth muscle cell senescence through PKA-dependent phosphorylation of AMPK\u03b1 at Ser485. FEBS Open Bio 10(7), 1316\u20131325 (2020).","journal-title":"FEBS Open Bio"},{"issue":"1","key":"49861_CR55","doi-asserted-by":"publisher","first-page":"F74","DOI":"10.1152\/ajprenal.00114.2017","volume":"313","author":"M Yi","year":"2017","unstructured":"Yi, M. et al. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am. J. Physiol. Renal Physiol. 313(1), F74\u2013F84 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"49861_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.125","volume":"6","author":"P Saurus","year":"2015","unstructured":"Saurus, P. et al. Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway. Cell Death Dis. 6, e1752 (2015).","journal-title":"Cell Death Dis."},{"issue":"12","key":"49861_CR57","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ki.2011.36","volume":"79","author":"K Mori","year":"2011","unstructured":"Mori, K., Mukoyama, M. & Nakao, K. PPAR-\u03b1 transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice. Kidney Int. 79(12), 1274\u20131276 (2011).","journal-title":"Kidney Int."},{"issue":"23","key":"49861_CR58","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1111\/bph.14822","volume":"176","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro. Br. J. Pharmacol. 176(23), 4558\u20134573 (2019).","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"49861_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ki.2010.137","volume":"78","author":"YS Kang","year":"2010","unstructured":"Kang, Y. S. et al. Inhibition of integrin-linked kinase blocks podocyte epithelial\u2013mesenchymal transition and ameliorates proteinuria. Kidney Int. 78(4), 363\u2013373 (2010).","journal-title":"Kidney Int."},{"issue":"5","key":"49861_CR60","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1681\/ASN.2007101109","volume":"19","author":"J Guo","year":"2008","unstructured":"Guo, J. et al. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. J. Am. Soc. Nephrol. 19(5), 961\u2013972 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"49861_CR61","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41598-018-36911-1","volume":"9","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Astragaloside IV inhibits glucose-induced epithelial\u2013mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-\u03baB p65 axis. Sci. Rep. 9(1), 323 (2019).","journal-title":"Sci. Rep."},{"issue":"2","key":"49861_CR62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/ijms18020305","volume":"18","author":"H Kim","year":"2017","unstructured":"Kim, H. et al. Anti-fibrotic effect of losartan, an angiotensin II receptor blocker, is mediated through inhibition of ER stress via up-regulation of SIRT1, followed by induction of HO-1 and thioredoxin. Int. J. Mol. Sci. 18(2), 305 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"49861_CR63","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1124\/jpet.109.161992","volume":"333","author":"JA Funk","year":"2010","unstructured":"Funk, J. A., Odejinmi, S. & Schnellmann, R. G. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells. J. Pharmacol. Exp. Ther. 333(2), 593\u2013601 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"49861_CR64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/JOE-18-0536","volume":"241","author":"W Han","year":"2019","unstructured":"Han, W. et al. SRT1720 retards renal fibrosis via inhibition of HIF1\u03b1\/GLUT1 in diabetic nephropathy. J. Endocrinol. 241, 85\u201398 (2019).","journal-title":"J. Endocrinol."},{"issue":"51","key":"49861_CR65","doi-asserted-by":"publisher","first-page":"88792","DOI":"10.18632\/oncotarget.21287","volume":"8","author":"Z Chen","year":"2017","unstructured":"Chen, Z. et al. Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission. Oncotarget 8(51), 88792\u201388803 (2017).","journal-title":"Oncotarget"},{"issue":"3","key":"49861_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193921","volume":"13","author":"S Yanagisawa","year":"2018","unstructured":"Yanagisawa, S. et al. The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure. PLoS\u00a0One 13(3), e0193921 (2018).","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"49861_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97839-7","volume":"11","author":"MC de Ponte","year":"2021","unstructured":"de Ponte, M. C. et al. Early type 1 diabetes aggravates renal ischemia\/reperfusion-induced acute kidney injury. Sci. Rep. 11(1), 19028 (2021).","journal-title":"Sci. Rep."},{"issue":"5","key":"49861_CR68","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ki.1987.262","volume":"32","author":"T Saito","year":"1987","unstructured":"Saito, T. et al. The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int. 32(5), 691\u2013699 (1987).","journal-title":"Kidney Int."},{"issue":"11","key":"49861_CR69","doi-asserted-by":"publisher","first-page":"F1295","DOI":"10.1152\/ajprenal.00471.2015","volume":"310","author":"FA Casare","year":"2016","unstructured":"Casare, F. A. et al. Renovascular remodeling and renal injury after extended angiotensin II infusion. Am. J. Physiol. Renal Physiol. 310(11), F1295\u2013F1307 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"49861_CR70","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/excr.1997.3739","volume":"236","author":"P Mundel","year":"1997","unstructured":"Mundel, P. et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236(1), 248\u2013258 (1997).","journal-title":"Exp. Cell Res."},{"issue":"1","key":"49861_CR71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12882-018-0968-4","volume":"19","author":"VG Cardoso","year":"2018","unstructured":"Cardoso, V. G. et al. Angiotensin II-induced podocyte apoptosis is mediated by endoplasmic reticulum stress\/PKC-\u03b4\/p38 MAPK pathway activation and trough increased Na. BMC Nephrol. 19(1), 179 (2018).","journal-title":"BMC Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49861-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T22:02:16Z","timestamp":1703023336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49861-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["49861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-49861-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22685"}}